BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 6410347)

  • 1. Current topics in the pathology of bladder cancer.
    Murphy WM
    Pathol Annu; 1983; 18 Pt 1():1-25. PubMed ID: 6410347
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of intravesical cisplatin and mitomycin-C for recurrent transitional cell carcinoma of bladder refractory to thiotepa.
    Mobley WC; Loening SA; Narayana AS; Culp DA
    Urology; 1986 Apr; 27(4):335-9. PubMed ID: 3083555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Possibilities and value of intracavitary and systemic chemotherapy of bladder cancer].
    Hofmann W; Langkopf B
    Z Urol Nephrol; 1982 Dec; 75(12):889-95. PubMed ID: 6819737
    [No Abstract]   [Full Text] [Related]  

  • 4. Intravesical and systemic chemotherapy in the management of superficial bladder cancer.
    Soloway MS
    Urol Clin North Am; 1984 Nov; 11(4):623-35. PubMed ID: 6438857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fifty-three month persistence of ring chromosome in noninvasive bladder carcinoma.
    Falor WH; Ward RM
    Acta Cytol; 1976; 20(3):272-5. PubMed ID: 1064279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Case 4. Perspectives in 2007 for bladder pathology. Giant cell urothelial carcinoma in situ].
    Mazerolles C
    Ann Pathol; 2008 Sep; 28(4):285-9. PubMed ID: 18928867
    [No Abstract]   [Full Text] [Related]  

  • 7. [Detection of urothelial carcinoma of the urinary bladder by multicolor fluorescence in situ hybridization].
    Zhang YG; Bi XG; Han YL; Cai Y; Xu X; Wu YP; Yang YL; Ma JH; Zhao P; Jia XM; Wang MR
    Ai Zheng; 2007 Feb; 26(2):189-93. PubMed ID: 17298751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytologic and histologic features of superficial bladder cancer.
    Ro JY; Staerkel GA; Ayala AG
    Urol Clin North Am; 1992 Aug; 19(3):435-53. PubMed ID: 1636229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The management of superficial bladder cancer.
    Soloway MS
    Cancer; 1980 Apr; 45(7 Suppl):1856-65. PubMed ID: 6768441
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pathomorphosis of bladder cancer after endolymphatic polychemotherapy].
    Danil'chenko SA; Shlopov VG; Serniak PS; Geev IuV
    Arkh Patol; 1986; 48(7):31-5. PubMed ID: 3092786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo assessment of urinary bladder malignancy.
    Karr JP; Pontes JE; Murphy GP; Gibas Z; Sandberg AA
    Prog Clin Biol Res; 1984; 162A():331-46. PubMed ID: 6592614
    [No Abstract]   [Full Text] [Related]  

  • 12. [Molecular cytogenetic study of bladder transitional cell carcinoma by FISH].
    Shou J; Wang M; Ma J
    Zhonghua Zhong Liu Za Zhi; 2000 Jan; 22(1):36-8. PubMed ID: 11776593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgery and intravesical chemotherapy in the management of superficial bladder cancer.
    Soloway MS
    Semin Urol; 1983 Feb; 1(1):23-33. PubMed ID: 6433424
    [No Abstract]   [Full Text] [Related]  

  • 14. [Recurrence rate in adjuvant local chemotherapy of bladder cancer with mitomycin C].
    Flüchter SH; Harzmann R; Erdmann D; Bichler KH
    Helv Chir Acta; 1982 Aug; 49(3-4):349-52. PubMed ID: 6813293
    [No Abstract]   [Full Text] [Related]  

  • 15. The pathology of human bladder cancer.
    Friedell GH; Parija GC; Nagy GK; Soto EA
    Cancer; 1980 Apr; 45(7 Suppl):1823-31. PubMed ID: 7370933
    [No Abstract]   [Full Text] [Related]  

  • 16. Carcinoma of the urinary bladder in patients receiving cyclophosphamide.
    Wall RL; Clausen KP
    N Engl J Med; 1975 Aug; 293(6):271-3. PubMed ID: 1138180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined thiotepa and mitomycin C instillation therapy for low-grade superficial bladder tumor.
    Hu KN; Kim A; Khan AS; Soroff H; Gonder M
    Cancer; 1985 Apr; 55(8):1654-8. PubMed ID: 3156664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbiopsy of the urinary bladder--a method involving minimal traumatization.
    Orell SR; Hultengren N
    Med J Aust; 1973 Mar; 1(11):539-41. PubMed ID: 4699729
    [No Abstract]   [Full Text] [Related]  

  • 19. [Dysplasias and carcinomas in situ of the urothelium].
    Mihatsch MJ
    Helv Chir Acta; 1985 Sep; 52(3-4):435-46. PubMed ID: 4066371
    [No Abstract]   [Full Text] [Related]  

  • 20. Intravesical thiotepa versus mitomycin C in patients with Ta, T1 and TIS transitional cell carcinoma of the bladder: a phase III prospective randomized study.
    Heney NM; Koontz WW; Barton B; Soloway M; Trump DL; Hazra T; Weinstein RS
    J Urol; 1988 Dec; 140(6):1390-3. PubMed ID: 3143016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.